Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
2-(2-Aminoethyl)benzimidazole dihydrochloride → Tricyclo[3.3.1.13,7]dec-2-yl (+/-)-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl]carbamate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 2-(2-Aminoethyl)benzimidazole dihydrochloride | HCID 2788071 | — |
| 반응물 | 2-adamantyloxycarbonyl-alpha-methyl-DL-tryptophan | HCID 14802503 | — |
| 용매 | Triethylamine | HCID 8471 | — |
| 생성물 | Tricyclo[3.3.1.13,7]dec-2-yl (+/-)-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl]carbamate | HCID 86747494 | — |
반응 단계
Following the procedure of Example 70, the title compound was prepared from 0.50 g (1.26 mmol) of 2-adamantyloxycarbonyl-α-methyl-DL-tryptophan and 0.33 g (1.41 mmol) of 1H-benzimidazole-2-ethanamine dihydrochloride with 0.5 mL of added triethylamine. The purified product after chromatography was obtained as a white foam, 0.38 g (56%); 1H NMR (CDCl3) δ1.46-1.91 (17H, m), 3.01-3.16 (2H, m), 3.27 (1H, d, J 15 Hz), 3.43 (1H, d, J 15 Hz), 3.58 (2H, m), 4.80 (1H, br s), 5.23 (1H, s), 6.67 (1H, m), 6.89-7.72 (10H, m), 8.28 (1H, br s).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05622983 |
| 출처 데이터셋 | uspto-grants-1997_04 |
| ORD ID | ord-391b5d5066a74c0abd4cbb3d88442d64 |
| 출처 메모 | uspto-grants-1997_04 |